Konstantin Mechler

Ultra-orphan diseases: a quantitative analysis of the natural history of molybdenum cofactor deficiency

Konstantin Mechler, William K. Mountford, Georg F. Hoffmann et al. · Genetics in Medicine · 2015 · 57 citations · Full text

Life Sciences, Biochemistry, Molecular Genetics +9

Pressure for drug development in lysosomal storage disorders – a quantitative analysis thirty years beyond the US orphan drug act

Konstantin Mechler, William K. Mountford, Georg F. Hoffmann et al. · Orphanet Journal of Rare Diseases · 2015 · 46 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16

FDA orphan drug designations for lysosomal storage disorders – a cross-sectional analysis

Sven F. Garbade, Matthias Zielonka, Konstantin Mechler et al. · PLoS ONE · 2020 · 41 citations · Full text

Pharmacy, Pharmacology, Drug Approval Processes +16

Personalized at‐home neurofeedback compared to long‐acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial

Diane Purper‐Ouakil, Hilario Blasco‐Fontecilla, Tomas Ros et al. · Journal of Child Psychology and Psychiatry · 2021 · 29 citations

Medicine, Pharmacotherapy, Psychiatry +16

Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) – study protocol for a randomised controlled trial

Alexander Häge, Tobias Banaschewski, Jan K. Buitelaar et al. · Trials · 2016 · 28 citations · Full text

Medicine, Pharmacology, Psychiatry +16